Clinical Trial Update: Fecal Microbiota Therapy for Recurrent Clostridium Difficile Colitis [NA]

View source ↗

Summary

Clinical trial update on fecal microbiota therapy for recurrent Clostridioides difficile infection, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: OSF Healthcare System | Conditions: Clostridium Difficile | NA | Status: UNKNOWN